Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | MicrobiomeTrials

← Back to trials

NCT05044819

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2021-07-07Est. Completion: 2027-08-01

Enrollment target: 154 participants

Locations

Clinical Trial Site, Little Rock, Arkansas, United States
Clinical Trial Site, Downey, California, United States
Clinical Trial Site, Long Beach, California, United States
Clinical Trial Site, Sacramento, California, United States
Clinical Trial Site, Miami, Florida, United States
Clinical Trial Site, Miami, Florida, United States
Clinical Trial Site, Orlando, Florida, United States
Clinical Trial Site, Tampa, Florida, United States
Clinical Trial Site, Augusta, Georgia, United States
Clinical Trial Site, Wichita, Kansas, United States
Clinical Trial Site, Lexington, Kentucky, United States
Clinical Trial Site, Baltimore, Maryland, United States
Clinical Trial Site, Boston, Massachusetts, United States
Clinical Trial Site, New Brunswick, New Jersey, United States
Clinical Trial Site, New York, New York, United States
Clinical Trial Site, Charlotte, North Carolina, United States
Clinical Trial Site, Durham, North Carolina, United States

Other microbiome trials you might be interested in

A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGSPhase 4Recruiting

Lennox-Gastaut Syndrome

This is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an ad…

New Orleans, United StatesEst. completion Dec 28, 2028

A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEEPhase 3Recruiting

Developmental and Epileptic Encephalopathy (DEE)

The efficacy, safety, and tolerability of CBD-OS have been evaluated for the treatment of seizures associated with Lenno…

Multiple LocationsEst. completion Sep 4, 2029

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.